Penumbra, Inc. (PEN)
335.85
-1.50
(-0.44%)
USD |
NYSE |
Mar 20, 16:00
335.88
+0.03
(+0.01%)
After-Hours: 20:00
Penumbra Research and Development Expense (Quarterly) : 17.52M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 569.00M |
| Revvity, Inc. | 58.18M |
| Abbott Laboratories | 721.00M |
| Alphatec Holdings, Inc. | 22.28M |
| Artivion, Inc. | 9.122M |